Sign up
Pharma Capital
Market: ASX
52-week High/Low: A$1.58 / A$0.53
Sector: Pharma & Biotech
Market Cap: A$113.83M

Cynata Therapeutics (ASX:CYP) is listed on the Australian Securities Exchange.

Cynata Therapeutics

Interactive graph

col 3
col 4
col 5
col 6
View full CYP profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.